Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.

Molecular medicine reports2012Yoshiji H, Noguchi R, Ikenaka Y, et al.

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2012
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Amino Acids, Branched-ChainAngiotensin-Converting Enzyme InhibitorsCollagen Type IVDrug Therapy, CombinationFemaleHumansHyaluronic AcidInsulin ResistanceLiver CirrhosisMaleMiddle AgedPerindoprilTransforming Growth Factor betaTreatment Outcome

DOI 10.3892/mmr.2011.676

PMID 22089860

View source →